BRICS Cancer Chemotherapy Market USD 6,140.1 Million in 2024 Projected to Witness Rapid Oncology Expansion to USD 14,315.4 Million by 2031
Growing awareness of early cancer diagnosis and treatment is contributing to higher therapy uptake rates. The BRICS Cancer Chemotherapy Market is estimated to record a CAGR of 12.9% from 2025 to 2031. Cancer chemotherapy remains one of the most widely used treatment modalities for managing various types of cancer, including lung, breast, colorectal, and hematological malignancies. In BRICS...
0 Σχόλια 0 Μοιράστηκε 363 Views 0 Προεπισκόπηση